ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes.

Jaquellyne Gurgel Penaforte-Saboia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.